CJC-1295 without DAC | Peptide Reference Material
RESEARCH PEPTIDE

CJC-1295 NO-DAC | MOLECULAR & ANALYTICAL RESEARCH

Modified GRF(1-29) — Short-Exposure GHRH Receptor Research Peptide
$49.00
CJC-1295 without DAC laboratory peptide reference material. CAS and material-form identity remain under scientific review. Research use only; not for human or veterinary use.
✓ Scientific Identity Established
⏳ Laboratory Testing In Progress
⏳ Batch Documentation Pending
✓ Research Use Only
✓ U.S. Fulfillment
In Laboratory Testing
Lot Verification Variant-specific documentation
Traceable Lots VBL lot identification
Primary Literature Peer-reviewed sources
Research Use Only Laboratory research materials

Scientific Specifications

Reference characteristics for laboratory research materials.

CAS Number
863288-34-0
Molecular Formula
C152H252N44O42
Molecular Weight
3367.9
Research Classification
Research Use Only (RUO). Not for human or veterinary use.

SCIENTIFIC OVERVIEW

Scientific background and research classification for this laboratory reference material.

This catalog material is labeled CJC-1295 without DAC / Modified GRF(1-29). Supplied records conflict on CAS and material form; no disputed sequence, formula, molecular mass, salt, or CAS value is adopted here. Research use only.

Primary Research Category
Growth Hormone Research
Material Type
Lyophilized Peptide
Intended Use
Laboratory Research
Research Categories
Growth Hormone Axis Receptor Pharmacology Pharmacokinetics

Mechanism of Action

Molecular interaction profile describing how this research material engages receptor systems and influences downstream biological signaling pathways.

No product-specific mechanism or pharmacokinetic property is assigned until the exact no-DAC material identity is independently resolved. CJC-DAC literature is not attributed to this material.

Primary Organ Systems
  • Endocrine System

Research Documentation

Laboratory documentation is presented when available for the selected product specification and current lot.

In Laboratory Testing
Laboratory Documentation In Progress

Laboratory documentation for the current lot is being completed.

Scientific References
Peer-Reviewed Literature

Explore published literature, clinical investigations, and foundational scientific research.

View References →
Laboratory Resources
Technical Guidance

Storage guidance, handling recommendations, analytical methods, and laboratory best practices.

Related Research
Companion Materials

Discover complementary research materials frequently studied alongside this compound.

Research Center

Scientific literature, laboratory resources, and related materials curated to support research involving this research material.

Scientific References
Peer-Reviewed Literature

Explore curated publications from peer-reviewed journals including clinical investigations, mechanistic studies, and foundational scientific literature.

Browse References →
Scientific Dossier
Deeper Technical Treatment

Comprehensive scientific documentation including literature review, mechanism, pharmacology, and study data for this research material.

Laboratory Resources
Technical Guidance

Storage guidance, handling information, analytical standards, research policies, and laboratory support documentation.

Research Library

Curated peer-reviewed literature selected to provide scientific context for this research material.

Clinical Trial•Journal of Clinical Endocrinology & Metabolism• 1994

Incorporation of D-Ala2 in growth hormone-releasing hormone-(1-29)-NH2 increases the half-life and decreases metabolic clearance in normal men

Direct human scaffold evidence for D-Ala2-stabilized GHRH(1-29)-NH2; not the complete tetrasubstituted no-DAC sequence.
Velora Research Insight
Included as scientific context at the stated evidence level; no finished-lot or therapeutic inference.
PubMed →DOI →
Mechanistic Study•Endocrinology• 2005

Human Growth Hormone-Releasing Factor (hGRF)1–29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog

Foundational comparison describing the tetrasubstituted backbone and showing that prolonged behavior derives from the added DAC moiety; not exact no-DAC PK evidence.
Velora Research Insight
Included as scientific context at the stated evidence level; no finished-lot or therapeutic inference.
PubMed →DOI →
Analytical Study•Analytical and Bioanalytical Chemistry• 2016

Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS

Analytical context for detecting synthetic GHRH analogs in plasma; does not establish therapeutic effects.
Velora Research Insight
Included as scientific context at the stated evidence level; no finished-lot or therapeutic inference.
PubMed →DOI →